CYTOMX THERAPEUTICS INC.
CTMX·23284F105·US·Common Stock·Healthcare - Biotechnology-13D/G
CTMX (CYTOMX THERAPEUTICS INC.) is held by 98 institutional investors as of Q1 2026. Largest holders: FMR LLC ($150.2M), BANK OF AMERICA CORP /DE/ ($48M), VANGUARD CAPITAL MANAGEMENT LLC ($41M). Net institutional sentiment: Bullish.
98
Holders
Avg rating(14 Elite)
$599.6M
Total Value
82% (103)
Fund Consensus
81 buying - 18 selling
Who's Trading
ActivistPAPerceptive Advisors LLC4.6%May 15, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.4.6%May 15, 2026
ActivistKYKynam Capital Management, LP6.9%May 15, 2026
ActivistPGPatrick G. Enright7.0%May 15, 2026
ActivistSFSeven Fleet Master Fund LP0.5%May 15, 2026
InsiderMAMcCarthy Sean A.Sell $764KMar 17, 2026
InsiderBMBELVIN MARCIASell $202KMar 17, 2026
InsiderOCOgden ChristopherSell $124KMar 17, 2026
InsiderCYChu Yu-WayeSell $137KMar 17, 2026
13F: Insider & Congress:
Showing 1-20 of 103
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer